Understanding Endoscopic Disease Activity in IBD: How to Incorporate It into Practice
- PMID: 26759147
- DOI: 10.1007/s11894-015-0477-6
Understanding Endoscopic Disease Activity in IBD: How to Incorporate It into Practice
Abstract
Endoscopic assessment of disease activity is an essential part of clinical practice in inflammatory bowel disease (IBD) and is used for diagnosis, prognosis, monitoring for dysplasia and increasingly for the evaluation of mucosal or endoscopic response to therapy. Recently, mucosal or endoscopic healing has emerged as a key goal of therapy as it has been found that patients who achieve endoscopic remission have improved outcomes compared to those who do not, and this may be independent of their clinical disease activity. However, there is currently no validated definition of mucosal healing and there are numerous endoscopic scoring systems proposed to define endoscopic activity and response to therapy in both ulcerative colitis and Crohn's disease. This article will discuss the most common endoscopic scores used to measure endoscopic disease activity in IBD, the pros and cons of each of these scoring systems and proposed definitions for endoscopic response or remission that exist for each. In addition, the role of endoscopy in prognosticating the disease course is discussed and how endoscopy can be utilized as part of a "treat-to-target" treatment strategy where endoscopy results direct decisions regarding medical strategies in clinical practice is highlighted.
Keywords: Colonoscopy; Crohn’s disease; Disease activity indices; Endoscopic disease activity; Inflammatory bowel disease; Mucosal activity; Mucosal healing; Ulcerative colitis.
Similar articles
-
Endoscopic scoring systems for inflammatory bowel disease: pros and cons.Expert Rev Gastroenterol Hepatol. 2014 Jul;8(5):543-54. doi: 10.1586/17474124.2014.899899. Epub 2014 Mar 20. Expert Rev Gastroenterol Hepatol. 2014. PMID: 24650249 Review.
-
Endoscopic Disease Activity in Inflammatory Bowel Disease.Curr Gastroenterol Rep. 2015 Dec;17(12):50. doi: 10.1007/s11894-015-0470-0. Curr Gastroenterol Rep. 2015. PMID: 26650939 Free PMC article. Review.
-
Definition and evaluation of mucosal healing in clinical practice.Dig Liver Dis. 2013 Dec;45(12):969-77. doi: 10.1016/j.dld.2013.06.010. Epub 2013 Aug 7. Dig Liver Dis. 2013. PMID: 23932331 Review.
-
Systematic review: histological remission in inflammatory bowel disease. Is 'complete' remission the new treatment paradigm? An IOIBD initiative.J Crohns Colitis. 2014 Dec;8(12):1582-97. doi: 10.1016/j.crohns.2014.08.011. Epub 2014 Sep 27. J Crohns Colitis. 2014. PMID: 25267173 Review.
-
Defining mucosal healing in randomized controlled trials of inflammatory bowel disease: A systematic review and future perspective.United European Gastroenterol J. 2024 Nov;12(9):1266-1279. doi: 10.1002/ueg2.12671. Epub 2024 Oct 5. United European Gastroenterol J. 2024. PMID: 39367753 Free PMC article. Review.
Cited by
-
Disease activity and mucosal healing in inflammatory bowel disease: a new role for histopathology?Virchows Arch. 2018 Jan;472(1):99-110. doi: 10.1007/s00428-017-2156-5. Epub 2017 May 30. Virchows Arch. 2018. PMID: 28555281 Review.
-
Correlation of Patient-Reported Outcome (PRO-2) with Endoscopic and Histological Features in Ulcerative Colitis and Crohn's Disease Patients.Gastroenterol Res Pract. 2020 Apr 2;2020:2065383. doi: 10.1155/2020/2065383. eCollection 2020. Gastroenterol Res Pract. 2020. PMID: 32328091 Free PMC article.
-
Correlation of mucosal healing endpoints with long-term clinical and patient-reported outcomes in ulcerative colitis.J Gastroenterol. 2023 Oct;58(10):990-1002. doi: 10.1007/s00535-023-02013-7. Epub 2023 Jul 25. J Gastroenterol. 2023. PMID: 37490069 Free PMC article. Clinical Trial.
-
Middle-term prognosis in patients with ulcerative colitis who achieved clinical and endoscopic remission by budesonide rectal foam.PLoS One. 2019 Aug 5;14(8):e0220413. doi: 10.1371/journal.pone.0220413. eCollection 2019. PLoS One. 2019. PMID: 31381615 Free PMC article. Clinical Trial.
-
Research-Based Product Innovation to Address Critical Unmet Needs of Patients with Inflammatory Bowel Diseases.Inflamm Bowel Dis. 2021 Nov 15;27(Suppl 2):S1-S16. doi: 10.1093/ibd/izab230. Inflamm Bowel Dis. 2021. PMID: 34791292 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous